RxDoctor Payments Data

Mark Hood, MD

Adult Reconstructive Orthopaedic Surgery · Indianapolis, INNPI 1699153148

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medinc Of Texas at 26.4% of the total. Reporting peaked in 2020 at $2,543 and has fallen 96.3% since, to $94 in 2025.

$7,098in general payments, 2019–2025

Across 78 payments — averaging $91.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medinc Of Texas$2K
  • Zimmer Biomet$2K
  • Stryker$1K
  • Johnson & Johnson$803
  • Medical Device Business Services, Inc.$313
  • Encore Medical, LP$284
  • plus $846 from 13 others

What the payments were for

  • Travel & lodging$1,00614%
  • Food & beverage$4,22059%
  • Education$1,87226%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$223,092
Medicare patients
365
Services billed
1,939

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium148$11,284
Meloxicam561$1,559
Enoxaparin Sodium14$1,418
Oxycodone Hcl170$1,081
Diclofenac Sodium ErDiclofenac Sodium44$1,067
Celecoxib19$474
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$376
Methylprednisolone31$143
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$134
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$134
Tramadol Hcl16$71
Amoxicillin69$56
Clindamycin Hcl13$14

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →